Associate Professor Kate Seear is an Australian Research Council Future Fellow and a Principal Research Fellow in the Australian Research Centre in Sex, Health and Society, La Trobe University. She is also a practising solicitor. Kate has a multidisciplinary background in sociology, gender and law. She is the author of four books and more than 70 academic publications, exploring topics such as: the links between alcohol, other drugs, stigma and the law; hepatitis C, harm reduction and the law; and drugs, gender, and human rights. Her most recent book is Law, drugs and the making of addiction: Just habits (London: Routledge) and was the winner of the UK’s prestigious Socio-Legal Studies Association’s History and Theory book prize. Kate is also the Co-Editor of the journal Contemporary Drug Problems.

Scientia Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies. Professor Dore established the St Vincent’s Hospital viral hepatitis service in 1999, and has led its development into one of the leading national and international HCV treatment services, with a particular focus on marginalised populations including people who inject drugs and homeless persons.

Associate Professor Kate Seear is an Australian Research Council Future Fellow and a Principal Research Fellow in the Australian Research Centre in Sex, Health and Society, La Trobe University. She is also a practising solicitor. Kate has a multidisciplinary background in sociology, gender and law. She is the author of four books and more than 70 academic publications, exploring topics such as: the links between alcohol, other drugs, stigma and the law; hepatitis C, harm reduction and the law; and drugs, gender, and human rights. Her most recent book is Law, drugs and the making of addiction: Just habits (London: Routledge) and was the winner of the UK’s prestigious Socio-Legal Studies Association’s History and Theory book prize. Kate is also the Co-Editor of the journal Contemporary Drug Problems.

Carrie Fowlie is the CEO of Hepatitis Australia the national peak body representing the interests of people impacted by viral hepatitis and the state and territory community hepatitis organisations. We want to end viral hepatitis and empower affected communities.

Dr. Feinberg's research program focuses on the intersection of the injection drug epidemic and its associated medical (overdose) and infectious complications (HIV, hepatitis B and C, endocarditis). In 2020, she developed the West Virginia Hepatitis Academic Mentoring Partnership (WVHAMP) to teach and support primary and addiction care providers to provide curative hepatitis C care in rural communities, and they have achieved a 99% SVR12 rate.

Professor Gail Matthews is Head of the Therapeutic Vaccine and Research Program (TVRP) at the Kirby Institute, UNSW as well as Head of Infectious Diseases at St Vincent’s Hospital. She has a strong background in HIV, viral hepatitis and strategic therapeutic clinical trials. As head of TVRP she leads several international clinical trials in HIV and COVID-19, as well as national projects in HCV and HBV. She works clinically as a specialist in HIV, Infectious Diseases and Viral Hepatitis at St Vincent’s Hospital, Sydney.